GB0125752D0 - Treatment of wet lung - Google Patents

Treatment of wet lung

Info

Publication number
GB0125752D0
GB0125752D0 GBGB0125752.6A GB0125752A GB0125752D0 GB 0125752 D0 GB0125752 D0 GB 0125752D0 GB 0125752 A GB0125752 A GB 0125752A GB 0125752 D0 GB0125752 D0 GB 0125752D0
Authority
GB
United Kingdom
Prior art keywords
treatment
wet lung
lung
wet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0125752.6A
Other versions
GB2370505A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Britannia Pharmaceuticals Ltd
Original Assignee
Britannia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Britannia Pharmaceuticals Ltd filed Critical Britannia Pharmaceuticals Ltd
Publication of GB0125752D0 publication Critical patent/GB0125752D0/en
Publication of GB2370505A publication Critical patent/GB2370505A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0125752A 2000-10-26 2001-10-26 Use of a surface active phospholipid in the manufacture of a powder medicament for the treatment of wet lung Withdrawn GB2370505A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0026239.4A GB0026239D0 (en) 2000-10-26 2000-10-26 Surface active lipids in treatment of wet lung

Publications (2)

Publication Number Publication Date
GB0125752D0 true GB0125752D0 (en) 2001-12-19
GB2370505A GB2370505A (en) 2002-07-03

Family

ID=9902029

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0026239.4A Ceased GB0026239D0 (en) 2000-10-26 2000-10-26 Surface active lipids in treatment of wet lung
GB0125752A Withdrawn GB2370505A (en) 2000-10-26 2001-10-26 Use of a surface active phospholipid in the manufacture of a powder medicament for the treatment of wet lung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0026239.4A Ceased GB0026239D0 (en) 2000-10-26 2000-10-26 Surface active lipids in treatment of wet lung

Country Status (3)

Country Link
AU (1) AU2002210720A1 (en)
GB (2) GB0026239D0 (en)
WO (1) WO2002034270A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003266884A1 (en) * 2002-09-16 2004-04-30 Vasogen Ireland Limited Accelerating recovery from trauma
WO2004082688A1 (en) * 2003-03-20 2004-09-30 Vasogen Ireland Limited Phosphatidylglycerol (pg) receptor agonists and antagonists
EP2308489B1 (en) 2009-10-05 2014-01-01 Nutri-Fit GmbH & Co. KG Compositions for use in treating or preventing metabolic stress-induced lung injury and methods for increasing physical capacity of mammalian livestock

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4312860A (en) * 1980-10-24 1982-01-26 Regents Of The University Of California Lung surfactant compositions
JPS58222022A (en) * 1982-06-21 1983-12-23 Teijin Ltd Synthetic pulmonary surface active substance and remedy for respiratory distress syndrome (rds) containing the same as active constituent
EP0110498B2 (en) * 1982-11-22 1991-09-18 Teijin Limited Artificial lung surfactant and remedy for respiratory distress syndrome containing it as active principle
JPS59164724A (en) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd Surfactant and remedy for respiratory distress syndrome containing the same
US5614216A (en) * 1990-10-17 1997-03-25 The Liposome Company, Inc. Synthetic lung surfactant
CO5021218A1 (en) * 1994-12-29 2001-03-27 Ct Nac De Sanidad Agropecuaria NATURAL SWIMMING PULMONARY SURFACTANT
DK1082108T3 (en) * 1997-12-03 2003-01-20 Britannia Pharmaceuticals Ltd Improvements in medication for asthma treatment
DE19827907C2 (en) * 1998-06-23 2003-05-15 Altana Pharma Ag New pharmaceutical compositions for the treatment of IRDS and ARDS

Also Published As

Publication number Publication date
GB2370505A (en) 2002-07-03
GB0026239D0 (en) 2000-12-13
AU2002210720A1 (en) 2002-05-06
WO2002034270A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
EG22308A (en) Tobacco treatment
AU4579401A (en) Lung treatment apparatus
GB0028264D0 (en) Well treatment
GB0007193D0 (en) Treatment of movrmrnt disorders
GB0028269D0 (en) Well treatment
AU5464601A (en) Treatment of scale
PL362855A1 (en) Improved treatment
EG25829A (en) Novel treatment
AU5040101A (en) Improved treatment of neovascularization
GB0004531D0 (en) The treatment of respiratory diseases
GB0030845D0 (en) Novel treatment
DE60144280D1 (en) Lung
AU9402401A (en) Treatment of cancers
GB0125752D0 (en) Treatment of wet lung
GB0020588D0 (en) Treatment of wounds
CA91213S (en) Rollator
GB0000442D0 (en) Web treatment
EP1303281A4 (en) Methods of treatment
GB0029125D0 (en) Novel treatment
GB0031321D0 (en) Treatment
GB0019728D0 (en) Novel treatment
GB0017952D0 (en) Treatment of dyskinesia
GB0014904D0 (en) Methods of treatment
GB0013928D0 (en) Methods of treatment
EP1158991A4 (en) Treatment of asthma

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)